<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Latest Biology Technology from Bio-Medicine.Org</title>
<link>http://www.bio-medicine.org/biology-technology-1/</link>
<description>Latest Biology Technology lists</description>
<language>en-us</language>
<copyright>Copyright 2007. Bio-Medicine All Rights Reserved.</copyright>
<item>
<title><![CDATA[Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Reportlinker-Adds-the-Clinical-Laboratory-Services-Market--28Growth-Opportunities--Competitive-Analysis-and-Competitor-Profiles-29-15558-1/</link>
<pubDate>Tue, 09 Feb 2010 12:27:57 MST</pubDate>
<description><![CDATA[NEW YORK ,  Feb. 9  /- Reportlinker.com announces that a new market research report is available in its catalogue:           The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)            http://www.reportlinker.com/p0176223/The-Clinical-Laboratory-Services-Market-Growth-Opportunities-Competitive... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds SNP Genotyping and Analysis Markets]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Reportlinker-Adds-SNP-Genotyping-and-Analysis-Markets-15557-1/</link>
<pubDate>Tue, 09 Feb 2010 12:27:31 MST</pubDate>
<description><![CDATA[NEW YORK ,  Feb. 9  /- Reportlinker.com announces that a new market research report is available in its catalogue:          SNP Genotyping and Analysis Markets           http://www.reportlinker.com/p0176225/SNP-Genotyping-and-Analysis-Markets.html          Because SNPs (single nucleotide polymorphisms),are the most common type of genetic variation betw... ]]></description>
</item>
<item>
<title><![CDATA[endpoint Saves Money and Time for Medical Research Teams Through PULSE]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/endpoint-Saves-Money-and-Time-for-Medical-Research-Teams-Through-PULSE-15556-1/</link>
<pubDate>Tue, 09 Feb 2010 09:45:36 MST</pubDate>
<description><![CDATA[SAN FRANCISCO ,  Feb. 9  /- endpoint Clinical ( www.endpointclinical.com ), a leader in Integrated Voice Response (IVR)/Integrated Web Response (IWR) systems, announced today that PULSE, a fully configurable platform that allows users to design and deploy clinical trial Integrated Response Technology (IRT) systems, saves 40 percent on the development time of c... ]]></description>
</item>
<item>
<title><![CDATA[Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Ardea-Biosciences-Announces-Appointment-of-Felix-J--Baker--Ph-D--to-Board-of-Directors-15555-1/</link>
<pubDate>Tue, 09 Feb 2010 09:45:29 MST</pubDate>
<description><![CDATA[SAN DIEGO ,  Feb. 9  /- Ardea Biosciences, Inc. (Nasdaq:  RDEA ) today announced that  Felix J. Baker , Ph.D., has been appointed to the Company's Board of Directors. &#160;Dr. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder.          "Ardea's impr... ]]></description>
</item>
<item>
<title><![CDATA[Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Tianyin-Pharmaceutical-Co---Inc--Expects-to-Benefit-from-the-Recently-Published-Guide-to-Pricing-Reform-for-Medicine-and-Medical-Services-15554-1/</link>
<pubDate>Tue, 09 Feb 2010 09:45:13 MST</pubDate>
<description><![CDATA[CHENGDU, China ,  Feb. 9  /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex:  TPI ), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in  Chengdu, China , today announced that it expects operational benefits from the recently published Guide to Reform of Pricing Mechanism... ]]></description>
</item>
<item>
<title><![CDATA[Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Peoria-Clinical-Research-Center-Tests-Investigational-Drug-to-Treat-Painful-Menstrual-Cramps-15553-1/</link>
<pubDate>Tue, 09 Feb 2010 09:45:00 MST</pubDate>
<description><![CDATA[PEORIA, Ariz. ,  Feb. 9  /- A leading clinical research center in  Peoria  has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in  the United States . Although not life threatening,... ]]></description>
</item>
<item>
<title><![CDATA[New Funding Validates Importance of Divergence&apos;s Work on Nematodes]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/New-Funding-Validates-Importance-of-Divergence-26apos-3Bs-Work-on-Nematodes-15552-1/</link>
<pubDate>Tue, 09 Feb 2010 09:07:40 MST</pubDate>
<description><![CDATA[Divergence receives grant funding of $500,000 to prevent crop damage by nematodes as the Divergence and National Corn Growers Association continues collaboration.                            (PRWEB) February 9, 2010 -- Divergence, Inc. announced today that the company has recently received two Small Business Innovation Research (SBIR) grants totaling $500,000, along with... ]]></description>
</item>
<item>
<title><![CDATA[United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/United-Therapeutics-Corporation-to-Announce-Fourth-Quarter-and-Annual-2009-Financial-Results-Before-Market-Open-on-Tuesday--February-16--2010-15551-1/</link>
<pubDate>Tue, 09 Feb 2010 06:44:23 MST</pubDate>
<description><![CDATA[SILVER SPRING, Md. ,  Feb. 9  /- United Therapeutics Corporation (Nasdaq:  UTHR ) announced today that it will release its fourth quarter and annual 2009 financial results before market open on  Tuesday, February 16, 2010 .         United Therapeutics will host a half-hour teleconference on  Tuesday, February 16, 2010 , at  9:00 a.m. Eastern Time . &#16... ]]></description>
</item>
<item>
<title><![CDATA[Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Agendia-Receives-New-York-State-Laboratory-Permit-and-Laboratory-Accreditation-by-College-of-American-Pathologists-15550-1/</link>
<pubDate>Tue, 09 Feb 2010 06:41:11 MST</pubDate>
<description><![CDATA[HUNTINGTON BEACH, California  and  AMSTERDAM ,  February 9  /- Agendia, a world leader in molecular cancer diagnostics, announced today that it has received the Clinical Laboratory Permit from the  New York State  Department of Health. The  New York State  permit allows the company to receive commercial samples of MammaPrint, its FDA-cleared breast cancer recur... ]]></description>
</item>
<item>
<title><![CDATA[CME Enterprise Named to Manage All Industry-Supported Symposia at 2010 APA Annual Meeting]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/CME-Enterprise-Named-to-Manage-All-Industry-Supported-Symposia-at-2010-APA-Annual-Meeting-15549-1/</link>
<pubDate>Tue, 09 Feb 2010 06:40:58 MST</pubDate>
<description><![CDATA[CARMEL, Ind. ,  Feb. 9  /- The American Psychiatric Association (APA) has chosen CME Enterprise as the sole medical education partner to prepare and manage all industry-supported symposia (ISS) programming at its annual meeting in  New Orleans, Louisiana , from  May 22-26, 2010 .          CME Enterprise will manage all elements of industry-supported symposia progr... ]]></description>
</item>
<item>
<title><![CDATA[Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Busy-Southwestern-Orthopedic-Practice-Joins-the-NeoStem-Stem-Cell-Collection-Network-15548-1/</link>
<pubDate>Tue, 09 Feb 2010 06:40:36 MST</pubDate>
<description><![CDATA[NEW YORK ,  Feb. 9  /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex:  NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and  China , announced today that its stem cell collection network has expanded into the southwestern region of the U.S. with the addition of the physician group at... ]]></description>
</item>
<item>
<title><![CDATA[ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/ThromboGenics---Positive-Microplasmin-Phase-II-Data-Published-in-Ophthalmology-15547-1/</link>
<pubDate>Tue, 09 Feb 2010 12:25:43 MST</pubDate>
<description><![CDATA[LEUVEN,  Belgium ,  February 9  /-              - Paper Examines the Potential of Microplasmin to Improve the Treatment of a Range of Back of the Eye Diseases              ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vasc... ]]></description>
</item>
<item>
<title><![CDATA[QIAGEN Acquires Exclusive Licence for Key PI3K gene]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/QIAGEN-Acquires-Exclusive-Licence-for-Key-PI3K-gene-15546-1/</link>
<pubDate>Mon, 08 Feb 2010 04:48:00 MST</pubDate>
<description><![CDATA[VENLO,  The Netherlands ,  February 8  /- QIAGEN (NASDAQ:  QGEN ; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from  Johns Hopkins University  to develop real-time-PCR and endpoint PCR assays. Research has shown that variati... ]]></description>
</item>
<item>
<title><![CDATA[Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Tianyin-Pharmaceutical-Co---Inc--Announces-Record-Second-Quarter-2010-Financial-Results-15545-1/</link>
<pubDate>Mon, 08 Feb 2010 04:47:56 MST</pubDate>
<description><![CDATA[CHENGDU, China ,  Feb. 8  /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in  Chengdu, China , today announced fiscal results for its second quarter ended  December 31, 2009 .         -- Q2 2010 Revenue Increased 47.9% to $14.9 Mi... ]]></description>
</item>
<item>
<title><![CDATA[YM BioSciences reports second quarter 2010 operational and financial results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/YM-BioSciences-reports-second-quarter-2010-operational-and-financial-results-15544-1/</link>
<pubDate>Mon, 08 Feb 2010 04:47:49 MST</pubDate>
<description><![CDATA[MISSISSAUGA, ON ,  Feb. 8  / YM BioSciences Inc. (NYSE  YMI, TSX: YM), today reported operational and financial results for the second quarter of fiscal 2010, ended  December 31, 2009 .         "After rigorous evaluation of numerous global in-licensing opportunities, we proposed to merge Cytopia Limited., a clinical-stage,  Melbourne -based drug developme... ]]></description>
</item>
<item>
<title><![CDATA[Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Astrogenetix-Continues-MRSA-Vaccine-Development-Onboard-Endeavor-15543-1/</link>
<pubDate>Mon, 08 Feb 2010 02:29:31 MST</pubDate>
<description><![CDATA[Space Shuttle Endeavor lifted off from NASA&rsquo;s Kennedy Space Center this morning, carrying on board the eighth scientific payload for Astrogenetix, a commercial biotech company created to use microgravity to develop the foundation of new medicines.                            (Vocus) February 8, 2010 -- Space Shuttle Endeavor lifted off from NASA&rsquo;s Kennedy Spa... ]]></description>
</item>
<item>
<title><![CDATA[Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries ]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Silicon-Kinetics-Announces-New-Biosensor-Chips-With-Wide-Palette-of-Surface-Chemistries--15542-1/</link>
<pubDate>Mon, 08 Feb 2010 09:49:59 MST</pubDate>
<description><![CDATA[The world's first 3D biosensor surface for label-free biomolecular interaction analysis now offers surface chemistries for: carboxyl, streptavidin, benzaldehyde, NTA-Ni for His-tagged proteins, Protein A and Protein G for coupling antibodies.                            San Diego, CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., the pioneering  life sciences tool co... ]]></description>
</item>
<item>
<title><![CDATA[China Medical Technologies to Participate Investor Conferences in March 2010]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/China-Medical-Technologies-to-Participate-Investor-Conferences-in-March-2010-15541-1/</link>
<pubDate>Mon, 08 Feb 2010 08:34:56 MST</pubDate>
<description><![CDATA[BEIJING ,  Feb. 8  /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq:  CMED ), a leading  China -based advanced in-vitro diagnostic ("IVD") company, today announced that it will participate at the following investor conferences in  March 2010 :           Investor Conference           Date               Location     Rodman &amp;... ]]></description>
</item>
<item>
<title><![CDATA[Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Biocell-Center-Furthers-Its-Commitment-to-Maternal-Fetal-Medicine-15540-1/</link>
<pubDate>Mon, 08 Feb 2010 08:34:52 MST</pubDate>
<description><![CDATA[MEDFORD, Mass. ,  Feb. 8  /- Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting.         "Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years," said  Kate Torchilin , CEO of Biocell... ]]></description>
</item>
<item>
<title><![CDATA[Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Corgenix-and-Tulane-Announce-Award-of-Additional-NIH-Contract-to-Expand-Lassa-Fever-Research-Towards-Development-of-Vaccines-and-Improved-Therapeutic--15539-1/</link>
<pubDate>Mon, 08 Feb 2010 08:34:47 MST</pubDate>
<description><![CDATA[DENVER  and  NEW ORLEANS ,  Feb. 8  /- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and  Tulane University , today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that will generate an additional  $800,000  in contract revenu... ]]></description>
</item>
</channel>
</rss>